Michael J B van Baar
7PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.Luxcia Kugathasan, Massimo Nardone, Marcel H A Muskiet
|May 06, 2025
Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial.Michaël J B van Baar, Marcel H A Muskiet, Rosalie A Scholtes
|Oct 31, 2019
Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.Erik J M van Bommel, Danique Ruiter, Marcel H A Muskiet
|Aug 07, 2019
The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.Michaël J B van Baar, Annemarie B van der Aart, Klaas Hoogenberg
|Mar 08, 2019
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?Rosalie A Scholtes, Michaël J B van Baar, Yuliya Lytvyn
|Jul 22, 2018
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.Michaël J B van Baar, Charlotte C van Ruiten, Marcel H A Muskiet
Pageof 2
Frequent Collaborators
3 joint publications
Max Nieuwdorp
2 joint publications
Petter Bjornstad
1 joint publications
Rosalie A Scholtes
1 joint publications
Yuliya Lytvyn
1 joint publications
Daniël H van Raalte
1 joint publications
Erik J M van Bommel
1 joint publications
David Z I Cherney
1 joint publications
Luxcia Kugathasan
1 joint publications
Ani Orchanian-Cheff
1 joint publications
Eugenio Cersosimo
